TY - JOUR
T1 - Geriatric Assessment in Older Adults with Multiple Myeloma
AU - Wildes, Tanya M.
AU - Tuchman, Sascha A.
AU - Klepin, Heidi D.
AU - Mikhael, Joseph
AU - Trinkaus, Kathryn
AU - Stockerl-Goldstein, Keith
AU - Vij, Ravi
AU - Colditz, Graham
N1 - Funding Information:
Financial Disclosure: This publication was made possible by Grant K12CA167540 through the National Cancer Institute (NCI) at the National Institutes of Health (NIH), Grant R03 AG042374 through the National Institute of Aging, and Grant UL1 TR000448 through the Clinical and Translational Science Award program of the National Center for Advancing Translational Sciences (NCATS) at the NIH. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCI, NCATS, or NIH.
Funding Information:
This publication was made possible by Grant K12CA167540 through the National Cancer Institute (NCI) at the National Institutes of Health (NIH), Grant R03 AG042374 through the National Institute of Aging, and Grant UL1 TR000448 through the Clinical and Translational Science Award program of the National Center for Advancing Translational Sciences (NCATS) at the NIH. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCI, NCATS, or NIH. T.W.: Research funding: Janssen. S.T: Speakers' bureau: Celgene; Research funding: Celgene, Takeda, J&J, Janssen, Prothena. H.K., J.M., K.T., K.S.G., R.V., and G.C. have nothing to disclose. T.W. designed the study and performed research, analyzed and interpreted data, and wrote the manuscript. S.T. contributed to acquisition of subjects, data interpretation, and manuscript preparation. H.K. contributed to data analysis and interpretation and manuscript preparation. J.M. contributed to research design, data interpretation, and manuscript preparation. K.T. performed data analysis and interpretation. K.S.G. contributed to acquisition of subjects, data interpretation, and manuscript preparation. R.V. contributed to acquisition of subjects, data interpretation, and manuscript preparation. G.C. contributed to study design, data interpretation, and manuscript preparation. The grant sponsors had no role in study design, methods, subject recruitment, data collection, analysis, or preparation of the manuscript.
Publisher Copyright:
© 2018 The American Geriatrics Society
PY - 2019/5
Y1 - 2019/5
N2 - BACKGROUND/OBJECTIVES: The incidence of myeloma in older adults is increasing, yet little is known about geriatric impairments in these patients. We aimed to examine the prevalence of geriatric impairments in older adults with myeloma and the association between geriatric assessment and autologous stem cell transplant eligibility. DESIGN: Prospective cohort study. SETTING: Two academic medical centers. PARTICIPANTS: A total of 40 adults 65 years and older with newly diagnosed myeloma were enrolled. MEASUREMENT: Participants completed a primarily self-administered geriatric assessment, including measures of functional status, comorbidities, polypharmacy, psychosocial status, social support, quality of life, cognition, and physical performance. Outcomes were autologous stem cell transplant eligibility and receipt. RESULTS: Forty patients enrolled; their mean age was 71 years. Geriatric impairments were common: 62% reported dependence in one or more instrumental activities of daily living (IADL), 76.9% had polypharmacy (four or more medications), and 47.5% had one or more comorbidities. Median time on the Timed Up and Go was 13.3 ± 4.9 seconds. Those considered candidates for autologous stem cell transplant (N = 26) were younger, with fewer comorbidities, better performance status, and faster performance on the Timed Up and Go test. Factors independently associated with receiving autologous stem cell transplant (N = 21) included age and IADL dependence. CONCLUSION: Impairments in geriatric domains are common in this population, even among those considered to have a good performance status. Geriatric assessment domains are associated with both transplant eligibility and receipt. J Am Geriatr Soc 67:987–991, 2019.
AB - BACKGROUND/OBJECTIVES: The incidence of myeloma in older adults is increasing, yet little is known about geriatric impairments in these patients. We aimed to examine the prevalence of geriatric impairments in older adults with myeloma and the association between geriatric assessment and autologous stem cell transplant eligibility. DESIGN: Prospective cohort study. SETTING: Two academic medical centers. PARTICIPANTS: A total of 40 adults 65 years and older with newly diagnosed myeloma were enrolled. MEASUREMENT: Participants completed a primarily self-administered geriatric assessment, including measures of functional status, comorbidities, polypharmacy, psychosocial status, social support, quality of life, cognition, and physical performance. Outcomes were autologous stem cell transplant eligibility and receipt. RESULTS: Forty patients enrolled; their mean age was 71 years. Geriatric impairments were common: 62% reported dependence in one or more instrumental activities of daily living (IADL), 76.9% had polypharmacy (four or more medications), and 47.5% had one or more comorbidities. Median time on the Timed Up and Go was 13.3 ± 4.9 seconds. Those considered candidates for autologous stem cell transplant (N = 26) were younger, with fewer comorbidities, better performance status, and faster performance on the Timed Up and Go test. Factors independently associated with receiving autologous stem cell transplant (N = 21) included age and IADL dependence. CONCLUSION: Impairments in geriatric domains are common in this population, even among those considered to have a good performance status. Geriatric assessment domains are associated with both transplant eligibility and receipt. J Am Geriatr Soc 67:987–991, 2019.
KW - aged
KW - elderly persons
KW - geriatric assessment
KW - hematopoietic stem cell transplantation
KW - multiple myeloma
UR - http://www.scopus.com/inward/record.url?scp=85058329394&partnerID=8YFLogxK
U2 - 10.1111/jgs.15715
DO - 10.1111/jgs.15715
M3 - Article
C2 - 30548581
AN - SCOPUS:85058329394
SN - 0002-8614
VL - 67
SP - 987
EP - 991
JO - Journal of the American Geriatrics Society
JF - Journal of the American Geriatrics Society
IS - 5
ER -